| scholarly article | Q13442814 |
| P50 | author | Ralph Steinman | Q105494 |
| Kayo Inaba | Q20982982 | ||
| Kristin V Tarbell | Q56250472 | ||
| P2093 | author name string | Sayuri Yamazaki | |
| P2860 | cites work | Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity | Q24302386 |
| Cutting Edge: TGF- Signaling Is Required for the In Vivo Expansion and Immunosuppressive Capacity of Regulatory CD4+CD25+ T Cells | Q58131166 | ||
| Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells | Q24306205 | ||
| Expression of the integrin alpha Ebeta 7 identifies unique subsets of CD25+ as well as CD25- regulatory T cells | Q24538658 | ||
| Essential role for CD103 in the T cell-mediated regulation of experimental colitis | Q24646106 | ||
| Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3 | Q24672849 | ||
| Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation | Q24676080 | ||
| Control of regulatory T cell development by the transcription factor Foxp3 | Q27860489 | ||
| Foxp3 programs the development and function of CD4+CD25+ regulatory T cells | Q27860714 | ||
| B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes | Q28143530 | ||
| Hassall's corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus | Q28268867 | ||
| Regulatory T cell lineage specification by the forkhead transcription factor foxp3 | Q28510328 | ||
| An essential role for Scurfin in CD4+CD25+ T regulatory cells | Q29618395 | ||
| Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self | Q29619194 | ||
| CD4+CD25+ Immunoregulatory T Cells Suppress Polyclonal T Cell Activation In Vitro by Inhibiting Interleukin 2 Production | Q29619536 | ||
| Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses | Q29619908 | ||
| Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice | Q30498716 | ||
| Regulatory T cells inhibit stable contacts between CD4+ T cells and dendritic cells in vivo | Q33236315 | ||
| An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation | Q33876035 | ||
| Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter | Q33936032 | ||
| A history of prostate cancer treatment | Q34013878 | ||
| Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance | Q34111451 | ||
| CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor | Q34116317 | ||
| Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells | Q34189120 | ||
| Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance. | Q34269503 | ||
| Effective expansion of alloantigen-specific Foxp3+ CD25+ CD4+ regulatory T cells by dendritic cells during the mixed leukocyte reaction | Q34479579 | ||
| Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. | Q34509694 | ||
| CD4(+)CD25(+) immunoregulatory T Cells: new therapeutics for graft-versus-host disease | Q34525987 | ||
| Interleukin 2 signaling is required for CD4(+) regulatory T cell function | Q34527240 | ||
| Human CD25+CD4+ T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells. | Q34529123 | ||
| In vivo instruction of suppressor commitment in naive T cells | Q34548023 | ||
| CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2. | Q34554035 | ||
| TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells | Q34556464 | ||
| Regulatory T cells in transplantation tolerance | Q35092535 | ||
| Therapeutic vaccination using CD4+CD25+ antigen-specific regulatory T cells | Q35867877 | ||
| Donor-specific transplantation tolerance: the paradoxical behavior of CD4+CD25+ T cells | Q35971446 | ||
| CD4+CD25+ T regulatory cells control anti-islet CD8+ T cells through TGF-beta-TGF-beta receptor interactions in type 1 diabetes | Q35978587 | ||
| Dominant tolerance: activation thresholds for peripheral generation of regulatory T cells | Q36061019 | ||
| Natural regulatory T cells in infectious disease | Q36078051 | ||
| Regulatory T cells and intestinal homeostasis | Q36079900 | ||
| Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation | Q36367099 | ||
| CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade | Q36369151 | ||
| Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation | Q36370863 | ||
| CD4+ CD25+ regulatory T cells control T helper cell type 1 responses to foreign antigens induced by mature dendritic cells in vivo | Q36371316 | ||
| Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells | Q36371345 | ||
| Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses | Q36376333 | ||
| The interactions of dendritic cells with antigen-specific, regulatory T cells that suppress autoimmunity | Q36392364 | ||
| CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. | Q36399104 | ||
| Developmental stage, phenotype, and migration distinguish naive- and effector/memory-like CD4+ regulatory T cells | Q36399149 | ||
| Essential role for interleukin-2 for CD4(+)CD25(+) T regulatory cell development during the neonatal period | Q36402733 | ||
| T cells that cannot respond to TGF-beta escape control by CD4(+)CD25(+) regulatory T cells | Q36402737 | ||
| Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization | Q36402763 | ||
| Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells. | Q36403529 | ||
| Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4+CD25+ regulatory T cell proliferation | Q36403539 | ||
| Induction of antigen-specific tolerance to bone marrow allografts with CD4+CD25+ T lymphocytes | Q40530227 | ||
| Large-scale in vitro expansion of polyclonal human CD4(+)CD25high regulatory T cells. | Q40565739 | ||
| In vitro-expanded human CD4(+)CD25(+) T-regulatory cells can markedly inhibit allogeneic dendritic cell-stimulated MLR cultures | Q40576782 | ||
| Induction of allopeptide-specific human CD4+CD25+ regulatory T cells ex vivo. | Q40643930 | ||
| Dendritic cells crossprime allo-specific self-restricted CD4(+) T cells after coculture with dead allogeneic cells | Q40724028 | ||
| Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. | Q40801370 | ||
| Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific | Q40910998 | ||
| Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood | Q41973912 | ||
| Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state | Q42466421 | ||
| Regulatory T-cell therapy: is it ready for the clinic? | Q43513695 | ||
| CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation | Q44408941 | ||
| Modulation of tryptophan catabolism by regulatory T cells. | Q44632333 | ||
| Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells | Q45878833 | ||
| Induction of T helper type 1-like regulatory cells that express Foxp3 and protect against airway hyper-reactivity | Q46061458 | ||
| Lymph node occupancy is required for the peripheral development of alloantigen-specific Foxp3+ regulatory T cells. | Q46499903 | ||
| Induction of antigen-specific immunologic tolerance by in vivo and in vitro antigen-specific expansion of naturally arising Foxp3+CD25+CD4+ regulatory T cells | Q47240621 | ||
| Cutting edge: IL-2 is critically required for the in vitro activation of CD4+CD25+ T cell suppressor function | Q47579310 | ||
| TGF-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes | Q47667692 | ||
| Natural and induced CD4+CD25+ cells educate CD4+CD25- cells to develop suppressive activity: the role of IL-2, TGF-beta, and IL-10. | Q47726082 | ||
| Cutting edge: human CD4+CD25+ T cells restrain the maturation and antigen-presenting function of dendritic cells | Q47810559 | ||
| Control of Foxp3+ CD25+CD4+ regulatory cell activation and function by dendritic cells | Q50095546 | ||
| L-Selectin(hi) but not the L-selectin(lo) CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection | Q50796687 | ||
| CD27/CFSE-based ex vivo selection of highly suppressive alloantigen-specific human regulatory T cells | Q51991426 | ||
| Toll-dependent control mechanisms of CD4 T cell activation | Q51996404 | ||
| Homing to suppress: address codes for Treg migration | Q53652321 | ||
| Cutting edge: CD4+CD25+ regulatory T cells impaired for intestinal homing can prevent colitis | Q53671891 | ||
| Engagement of glucocorticoid-induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4+CD25+ T cells | Q53883439 | ||
| P921 | main subject | dendritic cell | Q506253 |
| P304 | page(s) | 314-329 | |
| P577 | publication date | 2006-08-01 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Immunological Reviews | Q15724582 |
| P1476 | title | Dendritic cells expand antigen-specific Foxp3+ CD25+ CD4+ regulatory T cells including suppressors of alloreactivity | |
| P478 | volume | 212 |
| Q37267841 | A microsphere-based vaccine prevents and reverses new-onset autoimmune diabetes |
| Q40132561 | Adoptive T Regulatory Cell Therapy for Tolerance Induction |
| Q83485975 | Allogeneic apoptotic thymocyte‐stimulated dendritic cells expand functional regulatory T cells |
| Q36251019 | Alterations in regulatory T-cells: Rediscovered pathways in immunotoxicology |
| Q35637379 | Antigen‐specific blocking of CD4‐Specific immunological synapse formation using BPI and current therapies for autoimmune diseases |
| Q44448055 | Aryl Hydrocarbon Receptor Ligands in Cigarette Smoke Induce Production of Interleukin-22 to Promote Pancreatic Fibrosis in Models of Chronic Pancreatitis. |
| Q34170406 | Autologous apoptotic cells preceding transplantation enhance survival in lethal murine graft-versus-host models |
| Q30370021 | B2 cells suppress experimental abdominal aortic aneurysms. |
| Q36826059 | CD4+CD25+ regulatory T cells in transplantation: progress, challenges and prospects |
| Q33623556 | CD8+ CD205+ splenic dendritic cells are specialized to induce Foxp3+ regulatory T cells |
| Q84744532 | Cancer-derived matrix metalloproteinase-9 contributes to tumor tolerance |
| Q35865581 | Cellular immunotherapy using dendritic cells against multiple myeloma |
| Q47160335 | Characterization of alpha-fetoprotein effects on dendritic cell and its function as effector immune response activator |
| Q39061870 | Chronic helminth infection promotes immune regulation in vivo through dominance of CD11cloCD103- dendritic cells |
| Q37912653 | Clinical perspectives for regulatory T cells in transplantation tolerance |
| Q48554119 | Clinical scale electroloading of mature dendritic cells with melanoma whole tumor cell lysate is superior to conventional lysate co-incubation in triggering robust in vitro expansion of functional antigen-specific CTL |
| Q46759811 | Combined treatment with triptolide and rapamycin prolongs graft survival in a mouse model of cardiac transplantation. |
| Q37264541 | Combining Exosomes Derived from Immature DCs with Donor Antigen-Specific Treg Cells Induces Tolerance in a Rat Liver Allograft Model |
| Q59335606 | Contribution of Dendritic Cell Responses to Sepsis-Induced Immunosuppression and to Susceptibility to Secondary Pneumonia |
| Q45806642 | Controlling immune response and demyelination using highly potent bifunctional peptide inhibitors in the suppression of experimental autoimmune encephalomyelitis |
| Q79774513 | Cord blood dendritic cells prevent the differentiation of naïve T-helper cells towards Th1 irrespective of their subtype |
| Q26771142 | Crosstalk between innate and adaptive immunity in hepatitis B virus infection |
| Q34577734 | Defective IL-10 signaling in hyper-IgE syndrome results in impaired generation of tolerogenic dendritic cells and induced regulatory T cells. |
| Q26764858 | Dendritic Cell-based Immunotherapy for Rheumatoid Arthritis: from Bench to Bedside |
| Q35760835 | Dendritic Cells Regulate Treg-Th17 Axis in Obstructive Phase of Bile Duct Injury in Murine Biliary Atresia |
| Q34525480 | Dendritic Cells from Oral Cavity Induce Foxp3+ Regulatory T Cells upon Antigen Stimulation |
| Q38117138 | Dendritic Cells in the Periphery Control Antigen-Specific Natural and Induced Regulatory T Cells |
| Q21284774 | Dendritic cell-based approaches for therapeutic immune regulation in solid-organ transplantation |
| Q37448957 | Dendritic cell-based therapeutic cancer vaccines: what we have and what we need |
| Q37414951 | Dendritic cells as controllers of antigen-specific Foxp3+ regulatory T cells |
| Q41520681 | Dendritic cells in cancer immunotherapy: vaccines or autologous transplants? |
| Q37513871 | Dendritic cells in immunotherapy of established cancer: Roles of signals 1, 2, 3 and 4 |
| Q37008790 | Dendritic cells, the liver, and transplantation |
| Q34289152 | Designing Vaccines Based on Biology of Human Dendritic Cell Subsets |
| Q34707225 | Development of human CD4+FoxP3+ regulatory T cells in human stem cell factor-, granulocyte-macrophage colony-stimulating factor-, and interleukin-3-expressing NOD-SCID IL2Rγ(null) humanized mice |
| Q83142050 | Diltiazem induces regulatory T cellsin vitroby modulating human dendritic cell maturation |
| Q36804622 | Early increases in superantigen-specific Foxp3+ regulatory T cells during mouse mammary tumor virus infection |
| Q30992739 | Enhanced M1 macrophage polarization in human helicobacter pylori-associated atrophic gastritis and in vaccinated mice |
| Q37294572 | Ex vivo expansion of CD4(+)CD25(+) T regulatory cells for immunosuppressive therapy |
| Q37644169 | Ex-vivo tolerogenic F4/80⁺ antigen-presenting cells (APC) induce efferent CD8⁺ regulatory T cell-dependent suppression of experimental autoimmune uveitis. |
| Q36516599 | Experimental study of the mechanism of tolerance induction in dexamethasone-treated dendritic cells |
| Q36991445 | Fc-receptors as regulators of immunity. |
| Q36786930 | Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation |
| Q38289899 | Fusions of dendritic cells with breast carcinoma stimulate the expansion of regulatory T cells while concomitant exposure to IL-12, CpG oligodeoxynucleotides, and anti-CD3/CD28 promotes the expansion of activated tumor reactive cells |
| Q41957729 | Generation of stable Th1/CTL-, Th2-, and Th17-inducing human dendritic cells |
| Q37734329 | Helminths and dendritic cells: sensing and regulating via pattern recognition receptors, Th2 and Treg responses |
| Q37176591 | Host natural killer T cells induce an interleukin-4-dependent expansion of donor CD4+CD25+Foxp3+ T regulatory cells that protects against graft-versus-host disease |
| Q37524383 | Human FOXP3+ regulatory T cells in transplantation |
| Q36171406 | Human regulatory T cells: a unique, stable thymic subset or a reversible peripheral state of differentiation? |
| Q39633775 | IL-10 enhances promoter activity of ILT4 gene and up-regulates its expression in THP-1 cells |
| Q83191176 | IL-10-generated tolerogenic dendritic cells are optimal for functional regulatory T cell induction — A comparative study of human clinical-applicable DC |
| Q54943177 | Immature Dendritic Cell Therapy Confers Durable Immune Modulation in an Antigen-Dependent and Antigen-Independent Manner in Nonobese Diabetic Mice. |
| Q34400439 | Immune regulatory cells in umbilical cord blood and their potential roles in transplantation tolerance |
| Q48192448 | Immune roles of dendritic cells in stem cell transplantation. |
| Q34700675 | Immune suppression in head and neck cancers: a review |
| Q38080077 | Immunobiology of β-Cell Destruction |
| Q81239549 | Immunological mechanisms and clinical implications of regulatory T cell deficiency in a systemic autoimmune disorder: roles of IL-2 versus IL-15 |
| Q38071861 | Immunomodulation by helminth parasites: Defining mechanisms and mediators |
| Q38262108 | Immunopathogenesis of chronic hepatitis B. |
| Q90249347 | Immunosuppressive property of submandibular lymph nodes in patients with head and neck tumors: differential distribution of regulatory T cells |
| Q35852574 | Immunotherapy Using Dendritic Cells against Multiple Myeloma: How to Improve? |
| Q36243536 | Immunotherapy of cancer in 2012 |
| Q33747698 | Impaired Thymic Selection and Abnormal Antigen-Specific T Cell Responses in Foxn1Δ/Δ Mutant Mice |
| Q38194133 | Improving engraftment and immune reconstitution in umbilical cord blood transplantation |
| Q46009385 | Indefinite mouse heart allograft survival in recipient treated with CD4(+)CD25(+) regulatory T cells with indirect allospecificity and short term immunosuppression. |
| Q37223658 | Linked suppression across an MHC-mismatched barrier in a miniature swine kidney transplantation model |
| Q90346930 | Lkb1 in dendritic cells restricts CD8+Foxp3+regulatory T cells expansion in vivo |
| Q55172689 | Loss of Zbtb32 in NOD mice does not significantly alter T cell responses. |
| Q34342500 | Murine Langerin+ dermal dendritic cells prime CD8+ T cells while Langerhans cells induce cross-tolerance |
| Q34580296 | Nitric oxide controls an inflammatory-like Ly6C(hi)PDCA1+ DC subset that regulates Th1 immune responses |
| Q30438755 | Nitric oxide is a key component in inflammation-accelerated tumorigenesis |
| Q42253778 | PU.1-silenced dendritic cells prolong allograft survival in rats receiving intestinal transplantation |
| Q35185439 | Paramyxovirus infection regulates T cell responses by BDCA-1+ and BDCA-3+ myeloid dendritic cells |
| Q90330112 | Parasites-allergy paradox: Disease mediators or therapeutic modulators |
| Q36677698 | Phenotype of CD4+ T cell subsets that develop following mouse facial nerve axotomy |
| Q37735454 | Polarized dendritic cells as cancer vaccines: directing effector-type T cells to tumors |
| Q37762858 | Primary prevention of allergic diseases: current concepts and mechanisms |
| Q46834076 | Rapamycin-conditioned, alloantigen-pulsed dendritic cells promote indefinite survival of vascularized skin allografts in association with T regulatory cell expansion |
| Q80758878 | Reciprocal generation of Th1/Th17 and T(reg) cells by B1 and B2 B cells |
| Q36923001 | Regulation of dendritic cells by female sex steroids: relevance to immunity and autoimmunity |
| Q37101255 | Regulatory T cells and human disease |
| Q55399832 | Regulatory T-Cells: Potential Regulator of Tissue Repair and Regeneration. |
| Q37417069 | Rhesus monkey immature monocyte-derived dendritic cells generate alloantigen-specific regulatory T cells from circulating CD4+CD127-/lo T cells |
| Q26779405 | Role of Dendritic Cells in the Induction of Lymphocyte Tolerance |
| Q28742855 | SHIP-deficient dendritic cells, unlike wild type dendritic cells, suppress T cell proliferation via a nitric oxide-independent mechanism |
| Q37701348 | Self-tolerance and autoimmunity in a regulatory T cell model |
| Q37809744 | Shaping the T-cell repertoire in the periphery |
| Q79412051 | Skin controls immune regulators |
| Q36907769 | Specific alloantigen self-control by regulatory T cells in organ transplantation: a review |
| Q80118079 | Steady state dendritic cells with forced IDO expression induce skin allograft tolerance by upregulation of regulatory T cells |
| Q34628248 | Steady state migratory RelB+ langerin+ dermal dendritic cells mediate peripheral induction of antigen-specific CD4+ CD25+ Foxp3+ regulatory T cells |
| Q83463025 | Successful treatment of a refractory skin ulcer in chronic cutaneous GvHD after allogeneic HSCT with split-thickness skin allografting from the stem cell donor |
| Q37414418 | T regulatory cells: an overview and intervention techniques to modulate allergy outcome |
| Q37700178 | Th17 cells and Tregs: unlikely allies |
| Q58785770 | The Long Noncoding RNA MALAT1 Induces Tolerogenic Dendritic Cells and Regulatory T Cells miR155/Dendritic Cell-Specific Intercellular Adhesion Molecule-3 Grabbing Nonintegrin/IL10 Axis |
| Q38008353 | The ambiguity in immunology |
| Q24338766 | The aryl hydrocarbon receptor: a perspective on potential roles in the immune system |
| Q37959968 | The dendritic cell-regulatory T lymphocyte crosstalk contributes to tumor-induced tolerance |
| Q42954783 | The human "Treg MLR": immune monitoring for FOXP3+ T regulatory cell generation. |
| Q38535876 | The role of DCs in the immunopathogenesis of chronic HBV infection and the methods of inducing DCs maturation |
| Q44713464 | The similarities between smDCs and regDCs in alleviating the immune injury caused by transplantation of hepatocytes differentiated from ESCs |
| Q37164045 | Tolerance strategies for stem-cell-based therapies. |
| Q58615311 | Tolerising cellular therapies: what is their promise for autoimmune disease? |
| Q37353045 | Tolerogenic dendritic cell-regulatory T-cell interaction and the promotion of transplant tolerance |
| Q56896805 | Tolerogenic dendritic cells suppress murine corneal allograft rejection by modulating CD28/CTLA-4 expression on regulatory T cells |
| Q85329437 | Transient Treg-cell depletion in adult mice results in persistent self-reactive CD4(+) T-cell responses |
| Q99726047 | Treg Enhancing Therapies to Treat Autoimmune Diseases |
| Q38086155 | Tuning Cross-Presentation of Apoptotic T Cells in Immunopathology |
| Q37311069 | Tweaking the immune system: gene therapy-assisted autologous haematopoietic stem cell transplantation as a treatment for autoimmune disease. |
| Q33858279 | Umbilical cord-derived mesenchymal stem cells regulate thymic epithelial cell development and function in Foxn1(-/-) mice |
| Q86351769 | Use of dendritic cells in drug selection, development and therapy |
Search more.